Analysis of completeness of information for trial outcomes in CSRs versus publicly available sources, i.e., registry reports and/or journal publications.

Sample: all trials with both a CSR and a registry report and/or journal publication, n = 86).aTotal number of outcomes with complete information/total number of respective outcomes in sample.bCSRs submitted to regulatory authorities.cReports posted in trial results registries.dAEs of special interest in the given indication.样本：同时具备临床试验报告（CSR，Clinical Study Report）、注册报告及/或期刊发表文献的全部试验，样本量n=86。 a. 样本中具备完整信息的结局指标数/样本中对应结局指标的总数量； b. 提交至监管机构的临床试验报告； c. 发布于试验结果注册库的报告； d. 对应适应证中的特定关注不良事件（AEs，Adverse Events）。